drugset / Trial / NCT06394167
A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of intravenously administered VX-993 at different doses in healthy participants.
Timeline
- Start
- 2024-05-09
- Primary completion
- 2025-02-18
- Completion
- 2025-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VX-993 | Unknown | — | Intravenous |
Indications
No indication recorded.